Bone Therapeutics Raises €7.7M in Series D Funding
Bone Therapeutics, a Gosselies, Belgium-based biopharmaceutical company focused on innovative cell therapy products for the treatment of bone diseases, raised €7.7m in Series D funding. The financing includes: – €6.1m raised from existing investors (Nausicaa Ventures, BAMS Angels Fund I and Life Science Research Partners), and – €1.6m raised in grant subsidies from the Société […]